secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2025-09-10T23:59:59+00:00
Accession:  0000950170-25-113986
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Iterum shareholders reject say-on-pay, share increase, and equity plan at AGM
-----------------------------------------------------------------------------

- David Kelly elected Class I director with 10.8M for, 2.8M against, 0.7M abstain, 8.2M broker non-votes.
- Say-on-pay failed: 5.4M for (38.5%), 8.4M against, 0.5M abstain.
- Share capital increase to $2.6M (add 80M shares) rejected: 6.5M for, 15.8M against.
- Equity incentive plan amendment to add 4M shares rejected: 2.5M for, 11.3M against.
- Allotment authority and pre-emption opt-out also failed by wide margins.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000095017025113986/0000950170-25-113986-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000095017025113986/itrm-20250910.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-113986

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer